Diabetes Trials
Type 1 Diabetes, T1D, (NCT05565248)
Sponsors:
CRISPR Therapeutics AG
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Type 1 Diabetes, T1D, (NCT05210530)
Sponsors:
CRISPR Therapeutics
Indicator
IND Enabling
Phase I
Phase II
Phase III
close
Search CRISPR Medicine